[1]. D. Bonnefont-Rousselot J. P. Bastard et al.2000 Consequences of the diabetic status on the oxidant/antioxidant balance Diab. Metab. 26 163–176.

[1]. D. Bonnefont-Rousselot J. P. Bastard 2000 Consequences of the diabetic status on the oxidant/antioxidant balance Diab. Metab. 26 163–176.)| false
• Search Google Scholar
• Export Citation

[2]. M. R. Hayden S. C. Tyagi 2002 Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus Atheroscleropathy. Cardiovasc. Diabetol. 1 1–27.

[2]. M. R. Hayden S. C. Tyagi 2002 Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus Atheroscleropathy. Cardiovasc. Diabetol. 1 1–27.)| false
• Search Google Scholar
• Export Citation

[3]. G. Bugdayci N. Altan et al.2006 The effect of the sulfonylurea glyburide on glutathione-S-transferase and glucose-6-phosphate dehydrogenase in streptozotocin-induced diabetic rat liver Acta Diabetol. 43 131–134.

[3]. G. Bugdayci N. Altan 2006 The effect of the sulfonylurea glyburide on glutathione-S-transferase and glucose-6-phosphate dehydrogenase in streptozotocin-induced diabetic rat liver Acta Diabetol. 43 131–134.)| false
• Search Google Scholar
• Export Citation

[4]. C. Costagliola 1990 Oxidative state of glutathione in red blood cells and plasma of diabetic patients: in vivo and in vitro study Clin. Physiol. Biochem. 8 204–210.

[4]. C. Costagliola 1990 Oxidative state of glutathione in red blood cells and plasma of diabetic patients: in vivo and in vitro study Clin. Physiol. Biochem. 8 204–210.)| false
• Search Google Scholar
• Export Citation

[5]. X. M. Leverve B. Guigas et al.2003 Mitochondrial metabolism and type-2 diabetes: a specific target of metformin Diabetes Metab. 29 6S88–6S94.

[5]. X. M. Leverve B. Guigas 2003 Mitochondrial metabolism and type-2 diabetes: a specific target of metformin Diabetes Metab. 29 6S88–6S94.)| false
• Search Google Scholar
• Export Citation

[6]. J. Rysz R. Blaszczak et al.2007 Evaluation of selected parameters of the antioxidative system in patients with type 2 diabetes in different periods of metabolic compensation Arch. Immunol. Ther. Exp. 55 335–340.

[6]. J. Rysz R. Blaszczak 2007 Evaluation of selected parameters of the antioxidative system in patients with type 2 diabetes in different periods of metabolic compensation Arch. Immunol. Ther. Exp. 55 335–340.)| false
• Search Google Scholar
• Export Citation

[7]. T. Nishikawa D. Kukidome et al.2007 Impact of mitochondrial ROS production on diabetic vascular complications Diabetes Res. Clin. Pract. 77 S41–45.

[7]. T. Nishikawa D. Kukidome 2007 Impact of mitochondrial ROS production on diabetic vascular complications Diabetes Res. Clin. Pract. 77 S41–45.)| false
• Search Google Scholar
• Export Citation

[8]. E. Toth A. Racz et al.2007 Contribution of polyol pathway to arteriolar dysfunction in hyperglycemia. Role of oxidative stress, diminished NO and enhanced PGH2/TXA2 mediation Am. J. Physiol. Heart Circ. Physiol. 293 H3096–H30104.

[8]. E. Toth A. Racz 2007 Contribution of polyol pathway to arteriolar dysfunction in hyperglycemia. Role of oxidative stress, diminished NO and enhanced PGH2/TXA2 mediation Am. J. Physiol. Heart Circ. Physiol. 293 H3096–H30104.)| false
• Search Google Scholar
• Export Citation

[9]. C. M. Sena E. Nunes et al.2007 Endothelial dysfunction in type 2 diabetes: effect of antioxidants Rev. Port. Cardiol. 26 609–619.

[9]. C. M. Sena E. Nunes 2007 Endothelial dysfunction in type 2 diabetes: effect of antioxidants Rev. Port. Cardiol. 26 609–619.)| false
• Search Google Scholar
• Export Citation

[10]. R. A. Rabini N. Cester et al.1999 Modifications induced by LDL from type 1 diabetic patients on endothelial cells obtained from human umbilical vein Diabetes 48 2221–2228.

[10]. R. A. Rabini N. Cester 1999 Modifications induced by LDL from type 1 diabetic patients on endothelial cells obtained from human umbilical vein Diabetes 48 2221–2228.)| false
• Search Google Scholar
• Export Citation

[11]. R. M. F. Wever T. F. Lűscher et al.1998 Atherosclerosis and the two faces of endothelial nitric oxide synthase Circulation 97 108–112.

[11]. R. M. F. Wever T. F. Lűscher 1998 Atherosclerosis and the two faces of endothelial nitric oxide synthase Circulation 97 108–112.)| false
• Search Google Scholar
• Export Citation

[12]. L. D. Monti C. Barlassina et al.2003 Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome Diabetes 52 1270–1275.

[12]. L. D. Monti C. Barlassina 2003 Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome Diabetes 52 1270–1275.)| false
• Search Google Scholar
• Export Citation

[13]. G. M. Pieper 1999 Enhanced, unaltered and impaired nitric oxide-mediated endothelium dependent relaxation in experimental diabetes mellitus: importance of disease duration Diabetologia 42 204–213.

[13]. G. M. Pieper 1999 Enhanced, unaltered and impaired nitric oxide-mediated endothelium dependent relaxation in experimental diabetes mellitus: importance of disease duration Diabetologia 42 204–213.)| false
• Search Google Scholar
• Export Citation

[14]. S. Hollan 1996 Membrane fluidity of blood cells Haematologia (Budapest) 27 109–127.

[14]. S. Hollan 1996 Membrane fluidity of blood cells Haematologia (Budapest) 27 109–127.)| false
• Search Google Scholar
• Export Citation

[15]. Expert Committee 1997 Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabet. Care 201 183–197.

[15]. Expert Committee 1997 Report of the expert committee on the diagnosis and classification of diabetes mellitus Diabet. Care 201 183–197.)| false
• Search Google Scholar
• Export Citation

[16]. B. A. Shibib L. Khan R. Rahman 1993 Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase Biochem. J. 292 267–270.

[16]. B. A. Shibib L. Khan R. Rahman 1993 Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase Biochem. J. 292 267–270.)| false
• Search Google Scholar
• Export Citation

[17]. D. Gradinaru D. Margina N. Mitrea 2003 Study concerning the influence of antianginal therapy on the activity of endothelial nitric oxide synthase Farmacia 3 42–51.

[17]. D. Gradinaru D. Margina N. Mitrea 2003 Study concerning the influence of antianginal therapy on the activity of endothelial nitric oxide synthase Farmacia 3 42–51.)| false
• Search Google Scholar
• Export Citation

[18]. D. Margina M. Vladica et al.2005 Adiponectin level and NO synthesis as atherogenic markers at overweight and obese patients Pharmacia LII 68–70 (Фармация).

[18]. D. Margina M. Vladica 2005 Adiponectin level and NO synthesis as atherogenic markers at overweight and obese patients Pharmacia LII 68–70 (Фармация).)| false
• Search Google Scholar
• Export Citation

[19]. S. Shrivastava A. Chattopadhyay 2007 Influence of cholesterol and ergosterol on membrane dynamics using different fluorescent reporter probes Biochem. Biophys. Res. Commun. 356 705–710.

[19]. S. Shrivastava A. Chattopadhyay 2007 Influence of cholesterol and ergosterol on membrane dynamics using different fluorescent reporter probes Biochem. Biophys. Res. Commun. 356 705–710.)| false
• Search Google Scholar
• Export Citation

[20]. E. Katona G. Katona et al.2004 Drug Induced Membrane Effects in Metabolically Impaired and Nonimpaired Human T (Jurkat) Lymphoblastoid Cells Romanian J. Biophys. 14 29–36.

[20]. E. Katona G. Katona 2004 Drug Induced Membrane Effects in Metabolically Impaired and Nonimpaired Human T (Jurkat) Lymphoblastoid Cells Romanian J. Biophys. 14 29–36.)| false
• Search Google Scholar
• Export Citation

[21]. Lakowicz, J. R.: Principles of Fluorescence Spectroscopy, 2nd edition, Springer Science and Business Media Inc., 2004, pp. 298–299.

[21]. Lakowicz, J. R.: Principles of Fluorescence Spectroscopy, 2^nd edition, Springer Science and Business Media Inc., 2004, pp. 298–299.)| false
• Search Google Scholar
• Export Citation

[22]. W. J. Van Blitterswijk R. P. Van Hoeven B.W. Van der Meer 1981 Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements Biochim. Biophys. Acta 644 323–332.

[22]. W. J. Van Blitterswijk R. P. Van Hoeven B.W. Van der Meer 1981 Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements Biochim. Biophys. Acta 644 323–332.)| false
• Search Google Scholar
• Export Citation

[23]. D. Tsuda I. Nishio 2003 Insulin sensitivity, glucose metabolism, and membrane fluidity in hypertensive subjects Circulation 108 2653–2659.

[23]. D. Tsuda I. Nishio 2003 Insulin sensitivity, glucose metabolism, and membrane fluidity in hypertensive subjects Circulation 108 2653–2659.)| false
• Search Google Scholar
• Export Citation

[24]. N. F. Wiernsperger 1999 Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes Diabetes Metab. 25 110–127.

[24]. N. F. Wiernsperger 1999 Membrane physiology as a basis for the cellular effects of metformin in insulin resistance and diabetes Diabetes Metab. 25 110–127.)| false
• Search Google Scholar
• Export Citation

[25]. M. Sivonová I. Waczulíková et al.2004 The effect of Pycnogenol on the erythrocyte membrane fluidity Gen. Physiol. Biophys. 23 39–51.

[25]. M. Sivonová I. Waczulíková 2004 The effect of Pycnogenol on the erythrocyte membrane fluidity Gen. Physiol. Biophys. 23 39–51.)| false
• Search Google Scholar
• Export Citation

[26]. P. Carr N. A. Taub et al.1993 Human lymphocyte sodium-hydrogen exchange. The influences of lipids, membrane fluidity, and insulin Hypertension 21 344–352.

[26]. P. Carr N. A. Taub 1993 Human lymphocyte sodium-hydrogen exchange. The influences of lipids, membrane fluidity, and insulin Hypertension 21 344–352.)| false
• Search Google Scholar
• Export Citation

[27]. R. Beck S. Bertolino et al.1998 Vascular smooth muscle and endothelial cells modulation of arachidonic acid release and membrane fluidity by albumin Circ. Res. 83 923–931.

[27]. R. Beck S. Bertolino 1998 Vascular smooth muscle and endothelial cells modulation of arachidonic acid release and membrane fluidity by albumin Circ. Res. 83 923–931.)| false
• Search Google Scholar
• Export Citation

[28]. O. K. Baskurt A. Temiz H. J. Meiselman 1998 Effect of superoxide anions on red blood cell rheologic properties Free Radical Biol. Med. 24 102–110.

[28]. O. K. Baskurt A. Temiz H. J. Meiselman 1998 Effect of superoxide anions on red blood cell rheologic properties Free Radical Biol. Med. 24 102–110.)| false
• Search Google Scholar
• Export Citation

[29]. K. N. Hewitt E. A. Walker P.M. Stewart 2005 Hexose-6-phosphate dehydrogenase and redox control of 11-α-hydroxysteroid dehydrogenase type 1 activity Endocrinology 146 2539–2543.

[29]. K. N. Hewitt E. A. Walker P.M. Stewart 2005 Hexose-6-phosphate dehydrogenase and redox control of 11-α-hydroxysteroid dehydrogenase type 1 activity Endocrinology 146 2539–2543.)| false
• Search Google Scholar
• Export Citation

[30]. A. Wagle S. Jivraj et al.1998 Insulin regulation of glucose-6-phosphate dehydrogenase gene expression is rapamycin-sensitive and requires phosphatidylinositol 3-kinase J. Biol. Chem. 273 14968–14974.

[30]. A. Wagle S. Jivraj 1998 Insulin regulation of glucose-6-phosphate dehydrogenase gene expression is rapamycin-sensitive and requires phosphatidylinositol 3-kinase J. Biol. Chem. 273 14968–14974.)| false
• Search Google Scholar
• Export Citation